富安达医药创新混合A(011383)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
394,558.89 |
331,777.26 |
2,315,530.27 |
2,349,435.60 |
| 存出保证金 |
85,923.93 |
71,228.82 |
58,474.20 |
73,707.89 |
| 交易性金融资产 |
73,632,307.35 |
88,824,273.82 |
80,140,845.91 |
82,244,909.43 |
| 其中:股票投资 |
73,632,307.35 |
84,267,097.93 |
80,140,845.91 |
82,244,909.43 |
| 债券投资 |
- |
4,557,175.89 |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
1,515,779.38 |
- |
4,788,885.73 |
1,056,343.32 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
27,665.32 |
4,633.06 |
5,693.16 |
7,658.75 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
81,280,587.57 |
91,991,136.37 |
94,704,386.76 |
91,208,790.16 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
879,579.97 |
1,033,223.02 |
4,539,141.64 |
455,929.22 |
| 应付赎回款 |
80,057.12 |
105,330.96 |
96,298.51 |
70.64 |
| 应付管理人报酬 |
85,939.15 |
89,499.93 |
96,827.09 |
94,162.91 |
| 应付托管费 |
14,323.20 |
14,916.64 |
16,137.84 |
15,693.79 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
238,318.17 |
274,865.09 |
239,049.37 |
241,431.30 |
| 负债合计 |
1,298,217.61 |
1,517,835.64 |
4,987,454.45 |
807,287.86 |
| 所有者权益 |
| 实收基金 |
142,710,982.73 |
158,278,363.55 |
169,155,774.95 |
177,475,595.33 |
| 未分配利润 |
-62,728,612.77 |
-67,805,062.82 |
-79,438,842.64 |
-87,074,093.03 |
| 所有者权益合计 |
79,982,369.96 |
90,473,300.73 |
89,716,932.31 |
90,401,502.30 |
| 负债及所有者权益总计 |
81,280,587.57 |
91,991,136.37 |
94,704,386.76 |
91,208,790.16 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年